Aisling Capital Management LP Biomea Fusion, Inc. Transaction History
Aisling Capital Management LP
- $273 Million
- Q4 2024
A detailed history of Aisling Capital Management LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 798,757 shares of BMEA stock, worth $2.16 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
798,757
Previous 798,757
-0.0%
Holding current value
$2.16 Million
Previous $8.07 Million
61.58%
% of portfolio
1.14%
Previous 3.32%
Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
126Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$9.68 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$6.35 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$3.93 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$3.8 Million0.0% of portfolio
-
State Street Corp Boston, MA604KShares$1.64 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $79.4M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...